Characterization of IgD. I. Isolation of two molecular forms from human serum

G. Corte, P. Tonda, E. Cosulich, C. P. Milstein, A. Bargellesi, M. Ferrarini

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Human IgD present in the serum of normal individuals or of patients with Hodgkin's disease (having high IgD concentrations) was characterized and compared with five IgD myeloma proteins. IgD was isolated using a highly specific anti-δ insoluble immunoabsorbent from which the bound material was eluted with sodium dodecyl sulphate (SDS) or urea. The latter reagent could be removed by extensive dialysis, thus making possible the renaturation of the eluted molecules. The purity of the IgD thus isolated was confirmed by antigenic analysis. Both κ and λ light chain determinants were present on serum IgD, although λ light chain was predominant with a ratio of the κ chain of 2:1. SDS-polyacrylamide slab gel electrophoresis analysis revealed two different molecular forms of serum IgD, one (IgD1) migrating identically to monoclonal IgD, the other (IgD2) having a faster mobility. The difference between the two molecules was entirely, due to the different sizes of their constituent δ chains. Peptide mapping of the two chains (δ1 and δ2 respectively) and of the δ chain of an IgD myeloma protein was carried out using 125I-labelled material. The three molecules displayed a high degree of homology, the δ2 chain differing by the presence of three characteristic extra peptides. The significance of these extra peptides is discussed in the light of the peptide mapping technique employed.

Original languageEnglish
Pages (from-to)141-149
Number of pages9
JournalScandinavian Journal of Immunology
Volume9
Issue number2
Publication statusPublished - 1979

Fingerprint

Immunoglobulin D
Serum
Myeloma Proteins
Peptide Mapping
Sodium Dodecyl Sulfate
Light
Peptides
Hodgkin Disease
Urea
Polyacrylamide Gel Electrophoresis
Dialysis

ASJC Scopus subject areas

  • Immunology

Cite this

Corte, G., Tonda, P., Cosulich, E., Milstein, C. P., Bargellesi, A., & Ferrarini, M. (1979). Characterization of IgD. I. Isolation of two molecular forms from human serum. Scandinavian Journal of Immunology, 9(2), 141-149.

Characterization of IgD. I. Isolation of two molecular forms from human serum. / Corte, G.; Tonda, P.; Cosulich, E.; Milstein, C. P.; Bargellesi, A.; Ferrarini, M.

In: Scandinavian Journal of Immunology, Vol. 9, No. 2, 1979, p. 141-149.

Research output: Contribution to journalArticle

Corte, G, Tonda, P, Cosulich, E, Milstein, CP, Bargellesi, A & Ferrarini, M 1979, 'Characterization of IgD. I. Isolation of two molecular forms from human serum', Scandinavian Journal of Immunology, vol. 9, no. 2, pp. 141-149.
Corte G, Tonda P, Cosulich E, Milstein CP, Bargellesi A, Ferrarini M. Characterization of IgD. I. Isolation of two molecular forms from human serum. Scandinavian Journal of Immunology. 1979;9(2):141-149.
Corte, G. ; Tonda, P. ; Cosulich, E. ; Milstein, C. P. ; Bargellesi, A. ; Ferrarini, M. / Characterization of IgD. I. Isolation of two molecular forms from human serum. In: Scandinavian Journal of Immunology. 1979 ; Vol. 9, No. 2. pp. 141-149.
@article{6af0af88f0ff45329715a29babe3ff7e,
title = "Characterization of IgD. I. Isolation of two molecular forms from human serum",
abstract = "Human IgD present in the serum of normal individuals or of patients with Hodgkin's disease (having high IgD concentrations) was characterized and compared with five IgD myeloma proteins. IgD was isolated using a highly specific anti-δ insoluble immunoabsorbent from which the bound material was eluted with sodium dodecyl sulphate (SDS) or urea. The latter reagent could be removed by extensive dialysis, thus making possible the renaturation of the eluted molecules. The purity of the IgD thus isolated was confirmed by antigenic analysis. Both κ and λ light chain determinants were present on serum IgD, although λ light chain was predominant with a ratio of the κ chain of 2:1. SDS-polyacrylamide slab gel electrophoresis analysis revealed two different molecular forms of serum IgD, one (IgD1) migrating identically to monoclonal IgD, the other (IgD2) having a faster mobility. The difference between the two molecules was entirely, due to the different sizes of their constituent δ chains. Peptide mapping of the two chains (δ1 and δ2 respectively) and of the δ chain of an IgD myeloma protein was carried out using 125I-labelled material. The three molecules displayed a high degree of homology, the δ2 chain differing by the presence of three characteristic extra peptides. The significance of these extra peptides is discussed in the light of the peptide mapping technique employed.",
author = "G. Corte and P. Tonda and E. Cosulich and Milstein, {C. P.} and A. Bargellesi and M. Ferrarini",
year = "1979",
language = "English",
volume = "9",
pages = "141--149",
journal = "Scandinavian Journal of Immunology",
issn = "0300-9475",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Characterization of IgD. I. Isolation of two molecular forms from human serum

AU - Corte, G.

AU - Tonda, P.

AU - Cosulich, E.

AU - Milstein, C. P.

AU - Bargellesi, A.

AU - Ferrarini, M.

PY - 1979

Y1 - 1979

N2 - Human IgD present in the serum of normal individuals or of patients with Hodgkin's disease (having high IgD concentrations) was characterized and compared with five IgD myeloma proteins. IgD was isolated using a highly specific anti-δ insoluble immunoabsorbent from which the bound material was eluted with sodium dodecyl sulphate (SDS) or urea. The latter reagent could be removed by extensive dialysis, thus making possible the renaturation of the eluted molecules. The purity of the IgD thus isolated was confirmed by antigenic analysis. Both κ and λ light chain determinants were present on serum IgD, although λ light chain was predominant with a ratio of the κ chain of 2:1. SDS-polyacrylamide slab gel electrophoresis analysis revealed two different molecular forms of serum IgD, one (IgD1) migrating identically to monoclonal IgD, the other (IgD2) having a faster mobility. The difference between the two molecules was entirely, due to the different sizes of their constituent δ chains. Peptide mapping of the two chains (δ1 and δ2 respectively) and of the δ chain of an IgD myeloma protein was carried out using 125I-labelled material. The three molecules displayed a high degree of homology, the δ2 chain differing by the presence of three characteristic extra peptides. The significance of these extra peptides is discussed in the light of the peptide mapping technique employed.

AB - Human IgD present in the serum of normal individuals or of patients with Hodgkin's disease (having high IgD concentrations) was characterized and compared with five IgD myeloma proteins. IgD was isolated using a highly specific anti-δ insoluble immunoabsorbent from which the bound material was eluted with sodium dodecyl sulphate (SDS) or urea. The latter reagent could be removed by extensive dialysis, thus making possible the renaturation of the eluted molecules. The purity of the IgD thus isolated was confirmed by antigenic analysis. Both κ and λ light chain determinants were present on serum IgD, although λ light chain was predominant with a ratio of the κ chain of 2:1. SDS-polyacrylamide slab gel electrophoresis analysis revealed two different molecular forms of serum IgD, one (IgD1) migrating identically to monoclonal IgD, the other (IgD2) having a faster mobility. The difference between the two molecules was entirely, due to the different sizes of their constituent δ chains. Peptide mapping of the two chains (δ1 and δ2 respectively) and of the δ chain of an IgD myeloma protein was carried out using 125I-labelled material. The three molecules displayed a high degree of homology, the δ2 chain differing by the presence of three characteristic extra peptides. The significance of these extra peptides is discussed in the light of the peptide mapping technique employed.

UR - http://www.scopus.com/inward/record.url?scp=0018351307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018351307&partnerID=8YFLogxK

M3 - Article

C2 - 85332

AN - SCOPUS:0018351307

VL - 9

SP - 141

EP - 149

JO - Scandinavian Journal of Immunology

JF - Scandinavian Journal of Immunology

SN - 0300-9475

IS - 2

ER -